Gleneagles Clinical Research Services (India) Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 21-06-2024
- Paid Up Capital ₹ 2.20 Cr
as on 21-06-2024
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 8.50 Cr
as on 21-06-2024
- Revenue 40.04%
(FY 2020)
- Profit 32.18%
(FY 2020)
- Ebitda -108.37%
(FY 2020)
- Net Worth 1.57%
(FY 2020)
- Total Assets -15.45%
(FY 2020)
About Gleneagles Clinical Research Services (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.20 Cr.
The company has closed loans amounting to ₹8.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anurag Yadav and Jean Naa serve as directors at the Company.
- CIN/LLPIN
U85110TG2006PTC050946
- Company No.
050946
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2006
- Date of AGM
13 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Gleneagles Clinical Research Services (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anurag Yadav  | Nominee Director | 21-Nov-2017 | Current |
Jean Naa  | Nominee Director | 15-Jun-2019 | Current |
Financial Performance and Corporate Structure Insights of Gleneagles Clinical Research Services (India).
Gleneagles Clinical Research Services (India) Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 40.04% increase. The company also saw a substantial improvement in profitability, with a 32.18% increase in profit. The company's net worth moved up by a moderate rise of 1.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gleneagles Clinical Research Services (India)?
In 2020, Gleneagles Clinical Research Services (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Centre For Digestive And Kidney Diseases (India) Private LimitedActive 20 years 7 monthsAnurag Yadav and Jean Naa are mutual person
Gleneagles Healthcare India Private LimitedActive 26 years 2 monthsAnurag Yadav and Jean Naa are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Pradesh Sate Financial Corporation Creation Date: 21 Apr 2010 | ₹3.50 Cr | Satisfied |
Indian Overseas Bank Creation Date: 09 May 2009 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Gleneagles Clinical Research Services (India)?
Gleneagles Clinical Research Services (India) has a workforce of 11 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gleneagles Clinical Research Services (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gleneagles Clinical Research Services (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
